Cambridge Trust’s Axogen AXGN Stock Holding History

Cambridge Trust’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-130	Closed	-$1K	–	935
2021 Q4	$1K	Buy	+130	New	+$1.56K	﹤0.01%	979

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Cambridge Trust's AXGN Position: Q1 2022 in Review

Cambridge Trust sold out of Axogen (AXGN) in Q1 2022, closing a stake of 130 shares — an estimated $1K sold.

Cambridge Trust first reported a position in AXGN in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 132 funds tracked by Wall St. Rank hold AXGN as of Q1 2022.

Cambridge Trust reported no remaining Axogen position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 130 Axogen shares in Q1 2022, an estimated $1K.
Cambridge Trust first reported a position in Axogen in Q4 2021 and held it in 1 quarter.
Cambridge Trust's Axogen position peaked at $1K in Q4 2021.
132 funds tracked by Wall St. Rank held Axogen as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.